荷兰国家乳腺筛查项目20年乳腺X线筛查中筛查检出微小钙化的召回与结局
该回顾性分析纳入1997年至2017年间817 656次筛查检查,评估可疑微小钙化的召回率及病理结局。微小钙化召回率从1997-1998年的0.1%升至2015-2016年的0.5%(P < .001),与屏片乳腺X线摄影转为全视野数字乳腺X线摄影时间相关;召回后导管原位癌检出率从每1000次筛查0.3例升至1.1例(P < .001),导致召回阳性预测值从51%降至33%(P < .001)。
要点
- 筛查检出可疑微小钙化的召回率20年间由0.1%升至0.5%,与屏片转为数字乳腺X线摄影时间相关。
- 召回后导管原位癌检出率由每1000次筛查0.3例增至1.1例,但增幅小于召回率增幅。
- 可疑微小钙化召回的阳性预测值由51%降至33%,提示召回后良性活检比例增加。
关键影像表现/征象
- 筛查检出可疑微小钙化的召回率从1997-1998年的0.1%升至2015-2016年的0.5%(P < .001)。
- 召回后导管原位癌检出率从屏片期的每1000次筛查0.3例升至数字期的每1000次筛查1.1例(P < .001)。
- 全部导管原位癌中52.6%(393/747)为高级别,20年间导管原位癌分级分布稳定(P = .36)。
诊断标准与关键数值
- 可疑微小钙化召回的阳性预测值从屏片期的51%降至数字期的33%(P < .001)。
- 导管原位癌检出率:屏片期每1000次筛查0.3例 vs 数字期每1000次筛查1.1例(数字期升高)。
- 微小钙化召回率:1997-1998年0.1% vs 2015-2016年0.5%(2015-2016年升高,P < .001)。
临床应用与阅片要点
- 筛查阅片时需注意数字乳腺X线摄影对微小钙化的显示可能增加召回,但阳性预测值相应降低。
- 报告可疑微小钙化时应结合形态与分布描述,以协助评估活检必要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Trends in the detection of suspicious microcalcifications at mammography screening and the yield of these lesions after recall are unknown. Purpose To determine trends in recall and outcome of screen-detected microcalcifications during 20 years of mammography screening. Materials and Methods The authors performed a retrospective analysis of a consecutive series of 817 656 screening examinations (January 1997 to January 2017) in a national breast screening program. In 2009-2010 (transition period), screen-film mammography (SFM) was gradually replaced by full-field digital mammography (FFDM). The recalls of suspicious microcalcifications from all radiology reports and pathologic outcome of recalled women with 2-year follow-up were analyzed. Screening outcome in the era of SFM (1997-2008), the transition period (2009-2010), and the era of FFDM (2011-2016) were compared. Trends over time and variations between the SFM and FFDM periods were expressed by using proportions with 95% confidence intervals (CIs). In cases where the analysis based on the CI confirmed clear periods (eg, before and after introduction of FFDM), pre- and postchange outcomes were compared by using χ2 tests. Results A total of 18 592 women (median age, 59 years; interquartile range, 14 years) were recalled at mammography screening, 3556 of whom had suspicious microcalcifications. The recall rate for microcalcifications increased from 0.1% in 1997-1998 to 0.5% in 2015-2016 (P < .001). This was temporally associated with the change from SFM to FFDM. The recalls yielding ductal carcinoma in situ (DCIS) increased from 0.3 per 1000 screening examinations with SFM to 1.1 per 1000 screening examinations with FFDM (P < .001), resulting in a decrease in the positive predictive value for recall for suspicious microcalcifications from 51% to 33% (P < .001). More than half of all DCIS lesions were high grade (52.6%; 393 of 747). The distribution of DCIS grades was stable during the 20-year screening period (P = .36). Conclusion The recall rate for suspicious microcalcifications at mammographic screening increased during the past 2 decades, whereas the ductal carcinoma in situ detection rate increased less rapidly, resulting in a lower positive predictive value for recall. © RSNA, 2020.
引用
- Luiten JD, Voogd AC, Luiten EJT, et al. Recall and Outcome of Screen-detected Microcalcifications during 2 Decades of Mammography Screening in the Netherlands National Breast Screening Program. Radiology. 2020. PMID: 31990268. doi:10.1148/radiol.2020191266
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。